Danaher Co. (NYSE:DHR) Shares Sold by Jupiter Asset Management Ltd.

Jupiter Asset Management Ltd. decreased its position in shares of Danaher Co. (NYSE:DHRFree Report) by 11.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 223,627 shares of the conglomerate’s stock after selling 27,910 shares during the period. Jupiter Asset Management Ltd.’s holdings in Danaher were worth $51,334,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Hopwood Financial Services Inc. purchased a new stake in Danaher during the 4th quarter worth about $69,000. Farther Finance Advisors LLC increased its holdings in Danaher by 13.8% during the 4th quarter. Farther Finance Advisors LLC now owns 7,784 shares of the conglomerate’s stock worth $1,787,000 after purchasing an additional 943 shares during the period. Knuff & Co LLC increased its holdings in Danaher by 1.8% during the 4th quarter. Knuff & Co LLC now owns 8,407 shares of the conglomerate’s stock worth $1,930,000 after purchasing an additional 149 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Danaher by 51.9% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,440 shares of the conglomerate’s stock worth $560,000 after purchasing an additional 834 shares during the period. Finally, Sequoia Financial Advisors LLC increased its holdings in Danaher by 7.3% during the 4th quarter. Sequoia Financial Advisors LLC now owns 22,319 shares of the conglomerate’s stock worth $5,123,000 after purchasing an additional 1,516 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the company. Barclays cut their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. The Goldman Sachs Group set a $250.00 price objective on Danaher in a report on Wednesday, January 15th. Wells Fargo & Company dropped their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Finally, Citigroup dropped their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Read Our Latest Stock Analysis on DHR

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 11.10% of the stock is currently owned by insiders.

Danaher Stock Up 0.4 %

DHR opened at $206.01 on Wednesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The business has a 50 day simple moving average of $221.55 and a 200-day simple moving average of $241.74. The stock has a market capitalization of $147.24 billion, a P/E ratio of 39.02, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHRGet Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the company posted $2.09 earnings per share. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s payout ratio is currently 24.24%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.